Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study

Authors

  • Dragica Zendelovska Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Suzana Simeska Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Emilija Atanasovska Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Kalina Georgievska Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Igor Kikerkov Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Nikola Labachevski Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Krume Jakovski Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje
  • Trajan Balkanov Institute of Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University of Skopje, 50 Divizija 16, 1109 Skopje

DOI:

https://doi.org/10.3889/oamjms.2015.011

Keywords:

acyclovir, HPLC, human plasma, pharmacokinetic study, Zovirax

Abstract

BACKGROUND: The aim of this study is estimation of pharmacokinetic parameters: Cmax, tmax, t1/2, AUC0-t and AUC0-∞ with the two-way analysis of variance, single observation (ANOVA) for two preparations containing acyclovir.

OBJECTIVE: In order to evaluate pharmacokinetic study of acyclovir, method for quantitative determination of acyclovir in human plasma should be simple, rapid and reproducible. Therefore, the method is developed, validated and applied for analysis of acyclovir in plasma samples obtained from healthy volunteers.

MATERIAL AND METHODS: High performance liquid chromatographic (HPLC) method with UV-detection for the determination of acyclovir in human plasma is presented. This method involves protein precipitation with 20 % (V/V) perchloric acid. The chromatographic separation was accomplished on a reversed phase C8 column with a mobile phase composed of 0.1 % (v/v) triethylamine in water (pH 2.5). No internal standard is required. UV detection was set at 255 nm. The method was successfully applied for the evaluation of pharmacokinetic profiles of acyclovir tablets in 24 healthy volunteers.

RESULTS: The validation results shows that proposed method is rugged, precise (RSDs for intra- and inter-day precision ranged from 1.02 to 8.37 %) and accurate (relative errors are less than 6.66 %). The calibration curve was linear in the concentration range of 0.1-2.0 µg/ml and the limit of quantification was 0.1 µg/ml. The Cmax, tmax and AUCs for the two products were not statistically different (p>0.05), suggesting that the plasma profiles generated by Zovirax were comparable to those produced by acyclovir manufactured by Jaka 80 company.

CONCLUSION: Good precision, accuracy, simplicity, sensitivity and shorter time of analysis of the method makes it particularly useful for processing of multiple samples in a limited period of time for pharmacokinetic study of acyclovir.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Goodman and Gilman’s. The Pharmacological Basis of Therapeutics, 11th ed., McGrow Hill, New York, 2011: pp. 1247-1250.

Vo HC, Henning PA, Leung DT, Sacks SL. Development and validation of plasma assay for acyclovir using high-performance capillary electrophoresis with sample stacking. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 772 (2): 291-7.

Kishino S, Takekuma Y, Sugawara M, Shimamura T, Furukawa H, Todo S, Miyazaki K. Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection, J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 780 (2): 289-94.

Shao C, Dowling T, Haidar S, Yu LX, Polli JE, Kane MA. Quantification of acyclovir in human plasma by ultra-high-performance liquid chromatography-heated electrospray ionization-tandem mass spectrometry for bioequivalence evaluation. J Anal Bioanal Techniques. 2012; 3:4.

Perrottet N, Beguin A, Meylan P, Pascual M, Manuel O, Buclin T, Biollaz J, Decosterd LA. Determination of acyclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 852 (1-2): 420-9.

Dao YJ, Jiao Z, Zhong MK. Simultaneous determination of acyclovir, gagciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 867 (2): 270-6.

Zeng L, Math CE, Shaw PJ, Earl JW, McLachlan AJ. HPLC-fluorescence assay for acyclovir in children. Biomed Chromatogr. 2008; 22 (8): 879-87.

Emami J, Bazargan N, Ajami A. HPLC determination of acyclovir in human serum and its application in bioavailability studies. Research in Pharmaceutical Sciences. 2009; 4 (1): 47-54.

Bahrami G, Mirzaeei SH, Kiani A. Determination of acyclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 816 (1-2): 327-31.

Fernandez M, Sepulveda J, Aranguiz T, von Plessing C. Technique validation by liquid chromatography for the determination of acyclovir in plasma, J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 791 (1-2): 357-63.

Bangaru RA, Bansal YK, Rao AR, Gandhi TP. Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. J Chromatogr B Biomed Sci Appl. 2000; 739 (2): 231-7.

Brown SD, White CA, Chu CK, Bartlett MG. Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 772 (2): 327-34.

Tashima D, Otsubo K, Yoshida T, Itoh Y, Oishi R. A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2003; 17(8): 500-3.

Weller DR, Balfour HH Jr, Vezina HE. Simulatneous determination of acyclovir, ganciclovir and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography. Biomed Chromatogr. 2009; 23 (8): 822-7.

Sharma M, Nautiyal P, Jain S, Jain D. Simple and rapid RP-HPLC method for simultaneous determination of acyclovir and zodovudine in human plasma. J AOAC Int. 2010; 93 (5): 1462-7.

Published

2015-01-22

How to Cite

1.
Zendelovska D, Simeska S, Atanasovska E, Georgievska K, Kikerkov I, Labachevski N, Jakovski K, Balkanov T. Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study. Open Access Maced J Med Sci [Internet]. 2015 Jan. 22 [cited 2021 Sep. 22];3(1):32-6. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2015.011

Issue

Section

A - Basic Science